Jens A. Lange

No ORCID on file · 3 papers in corpus
article 2022
Pregnancy and pregnancy outcomes in a prospective cohort study: Final results from the Nexplanon Observational Risk Assessment Study (NORA)
·doi:10.1016/j.contraception.2022.109920

ObjectivesTo monitor pregnancy occurrence and outcomes among Nexplanon users in the United States during standard clinical practice.Study designThe Nexplanon Observational Risk Assessment (NORA) study was a large prospective cohort study co…

article 2021
Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study
·doi:10.1177/2284026521993688

Introduction: The Visanne Post-approval Observational Study (VIPOS) was designed to assess the safety of dienogest 2 mg (DNG, Visanne) compared to other hormonal endometriosis treatments. Methods: Large, prospective, non-interventional, act…

article 2020
Risk of depression and anemia in users of hormonal endometriosis treatments: Results from the VIPOS study
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.05.049

ObjectiveDienogest (DNG) 2 mg (Visanne) was launched for endometriosis treatment in Europe in 2010. The Visanne Post-approval Observational Study (VIPOS) was designed to assess the safety of DNG 2 mg/day compared to other hormonal endometri…